CRISPR Therapeutics is a biotech company focused on gene-editing therapies using CRISPR-Cas9 technology to treat genetic diseases. Its research includes potential cures for sickle cell disease, cancer, and other genetic disorders.
Ticker code: CRSP
Sector: Healthcare | Industry: Biotechnology | Website: https://www.crisprtx.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $5,535,990,550 | $3,831,304,598 | 95300233.0 | 99.48 | $5,507,037,332 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $1,945,077,656 | $1,915,709,952 | $211,024,000 | -24.5 | -916.1 | -87.6 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Positive | 8.4 | $76,405,951 | $147,725,310 | None | 0.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $58.090 | 0.9 | 2.1 | 11.3 | 13.5 | 77.9 | 21.6 |
CRSP Price Chart with Volume and 3EMA
CRSP Short Positions
No chart available for this company.
Click HERE to understand why the above moving averages have been chosen.